SHANGHAI GROWTH (00770): Li Canhua appointed as independent non-executive director.

22:57 30/01/2026

SHANGHAI GROWTH (00770) announced that Mr. Li Canhua has been appointed as an independent non-executive director, chairman of the Audit Committee, and member of the Remuneration Committee with effect from January 30, 2026; Ms. Zhang Yuefen has resigned from the positions of Company Secretary, Authorized Representative, and agent for accepting legal process documents; Ms. Liu Meixue has resigned as an independent non-executive director and no longer serves as chairman of the Audit Committee and Nomination Committee, as well as a member of the Remuneration Committee, and has been appointed as Company Secretary, Authorized Representative, and agent for accepting legal process documents; Ms. Shi Meiling has been appointed as chairman of the Nomination Committee.

Shanghai Growth (00770) announced that as of January 30, 2026, Mr. Li Canhua has been appointed as an independent non-executive director, chairman of the audit committee, and member of the remuneration committee; Ms. Zhang Yuefen has resigned from the positions of company secretary, authorized representative, and agent for accepting legal process documents; Ms. Liu Meixue has resigned as an independent non-executive director, and no longer serves as chairman of the audit committee and nomination committee, as well as a member of the remuneration committee, and has been appointed as company secretary, authorized representative, and agent for accepting legal process documents; Ms. Shi Meiling has been appointed as chairman of the nomination committee.

Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.

US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.

US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.

Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.

US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.

US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.